Department of Surgery, Drug Research and Development Center, Federal University of Ceara , Fortaleza , Brazil.
Department of Physiology and Pharmacology, Drug Research and Development Center, Federal University of Ceara , Fortaleza , Brazil.
Epigenetics. 2019 Dec;14(12):1164-1176. doi: 10.1080/15592294.2019.1640546. Epub 2019 Jul 13.
Growing evidence suggests that aberrant epigenetic regulation of gene function is strongly related to the genesis of cancer. Unlike genetic mutations, the ability to reprogram the epigenetic landscape in the cancer epigenome is one of the most promising target therapies in both treatment and reversibility of drug resistance. Epigenetic alterations in cancer development and progression may be the basis for the individual variation in drug response. Thus, this review focuses on the emerging area of pharmaco(epi)genomics, specifically highlighting epigenetic reprogramming during tumorigenesis and how epigenetic markers are targeted as a therapy (epidrugs) and the clinical implications of this for cancer treatment.
越来越多的证据表明，基因功能的表观遗传调控失常与癌症的发生密切相关。与基因突变不同，在癌症表观基因组中重新编程表观遗传景观的能力是治疗和逆转耐药性最有前途的靶向治疗之一。癌症发生和发展中的表观遗传改变可能是药物反应个体差异的基础。因此，本综述侧重于药物基因组学（epi）的新兴领域，特别是强调肿瘤发生过程中的表观遗传重编程，以及如何将表观遗传标记作为一种治疗方法（epidrugs）进行靶向治疗，以及这对癌症治疗的临床意义。
